U.S. FDA

@FDA · Silver Spring, MD · joined 26 Oct 2010

Our posts are FDA Approved! Privacy Policy - https://t.co/LbTJXYRXVP FDA Authentic Accounts - https://t.co/w2LNbzG7M0

592 821Followers

103Following

22 425Posts total

579.9KViews on collected posts

Последние посты

U.S. FDA@FDA15 Sep

@FDA $NWBO is the pinnacle of a therapeutic that has been unjustly manipulated out of the US, despite having the best efficacy in GBM in a long freaking time. Patients are desperate and need hope. Their hope has been sent to the UK. Restore the hope to the US. Grant $NWBO an 2.5K views · 125 likes · 26 reposts · 2 replies Open on X →

U.S. FDA@FDA15 Sep

@FDA How about a company located 5 miles from your HQ having their non toxic treatment (and highly effective) only available in the UK. Talk is cheap, NWBO has the best treatment for GBM on the planet, it is already saving lives when US doctors say they have no options but awful 1.4K views · 45 likes · 12 reposts · 1 replies Open on X →

U.S. FDA@FDA15 Sep

@FDA But they do have to. Ask @HollensbeAmanda & @HollensbeBrae. They have to travel to the UK for a non-toxic treatment developed by an American company. The FDA has been well aware of this company for more than a decade. Six market makers are being sued for spoofing t 2.3K views · 115 likes · 27 reposts · 3 replies Open on X →

U.S. FDA@FDA15 Sep

American patients shouldn't have to travel abroad to access treatments discovered here. American innovators shouldn't have to go elsewhere to test them. FDA's Expedited IND Pilot is part of the Trump Administration’s broader effort to make the U.S. the fastest, safest path from h

83.8K views · 388 likes · 69 reposts · 66 replies Open on X →

U.S. FDA@FDA15 Sep

$NWBO - Read these words from a mom who was told three years ago her teenage daughter had brain cancer and months to live “I have been waiting almost 3 years to write these words: NO EVIDENCE OF DISEASE. 🙏❤️ ….There is NO VISIBLE TUMOR. Even the ~10% Dr. Liau had to leave ht

10.1K views · 254 likes · 66 reposts · 8 replies Open on X →

U.S. FDA@FDA15 Sep

I have been waiting almost 3 years to write these words: NO EVIDENCE OF DISEASE. 🙏❤️ Today we met with Braelyn’s neurosurgeon, Dr. Linda Liau at UCLA (telehealth). When our local radiologist read Braelyn’s August 28 MRI as “no evidence of disease recurrence,” we were https://

119.7K views · 978 likes · 203 reposts · 164 replies Open on X →

U.S. FDA@FDA12 Sep

We approved the first therapy to directly target muscle weakness linked to muscle loss in patients with the rare disease of spinal muscular atrophy (SMA). Designed to work alongside existing SMA treatments, it helps patients age 2 and older improve their strength and function. ht

21.2K views · 84 likes · 14 reposts · 12 replies Open on X →

U.S. FDA@FDA11 Sep

FYI: FDA does NOT provide certificates or other documents to verify compliance for cosmetic product facility registration or cosmetic product listing. These products are regulated by the FDA, but do not receive special certification. https://t.co/1uCCA7Iv2z

8.8K views · 16 likes · 2 reposts · 7 replies Open on X →

U.S. FDA@FDA11 Sep

Registration is now open to attend “Patient Voice in Rare Disease Medical Product Development.” https://t.co/AV2cBOGE7q This hybrid public meeting, co-hosted by @FDA and @reaganudall, will explore the patient voice in rare disease medical product development. https://t.co/oRaOjY

9.5K views · 32 likes · 8 reposts · 3 replies Open on X →

U.S. FDA@FDA11 Sep

The @CDCgov has declared the Taylor Farms–related Cyclospora outbreak over. The FDA’s investigation and related activities remain ongoing. https://t.co/VCU5omXNCD See our new post-response page to learn more about the agency’s continued work and future efforts. https://t.co/WYmq

194.9K views · 113 likes · 38 reposts · 17 replies Open on X →

U.S. FDA@FDA11 Sep

On the 25th anniversary of September 11, we remember the lives lost and the families and communities forever changed by the events of that day. We honor the courage and selflessness of the first responders who came to the aid of others, and all those who answered the call to htt

9.7K views · 57 likes · 12 reposts · 6 replies Open on X →

U.S. FDA@FDA4 Sep

High standards must apply to every trial, wherever it might be conducted. The FDA is expanding oversight of foreign clinical trial sites, adding inspection resources, and increasing scrutiny of data from sites we cannot access. https://t.co/RrHOdMiJVP https://t.co/ntzmvd6yI0 15.3K views · 47 likes · 15 reposts · 8 replies Open on X →

U.S. FDA@FDA2 Sep

Clinical trial data — wherever collected — must be reliable, inspectable, and ethically derived. If FDA can't inspect a site, that's a material factor in your regulatory strategy, not a footnote. Good clinical practice protects patients. The FDA will enforce it. https://t.co/AYl 40.7K views · 123 likes · 26 reposts · 16 replies Open on X →

U.S. FDA@FDA1 Sep

@FDA @SECGov @kshaughnessy2 Wondered what you think about this one, sounds promising but will believe it when I see it. 🤔 153 views · 4 likes · 0 reposts · 1 replies Open on X →

U.S. FDA@FDA1 Sep

@FDA @SECGov I simply cannot understand why the FDA is blocking ANKTIVA. Please explain it to me. From everything I can see right now, the FDA is not treating ImmunityBio fairly. So you can write whatever you want — to me, something about this just doesn't add up. It smells like 120 views · 4 likes · 0 reposts · 0 replies Open on X →

U.S. FDA@FDA1 Sep

@FDA @SECGov Yeah ok! Believe it when we see it!! 299 views · 7 likes · 0 reposts · 0 replies Open on X →

U.S. FDA@FDA31 Aug

We’ve teamed up with the @SECGov via a new Memorandum of Understanding to enhance cooperation across the life sciences sector. Greater transparency strengthens accountability and boosts regulatory predictability—meaning patients win. Read more: https://t.co/qJtdD4nIze 18.1K views · 27 likes · 7 reposts · 14 replies Open on X →

U.S. FDA@FDA28 Aug

@FDA @GeneralMills https://t.co/Pc91BzNApN 116 views · 2 likes · 0 reposts · 0 replies Open on X →

U.S. FDA@FDA27 Aug

@FDA @GeneralMills FDA no longer has any credibility. Most of your employees are on boards of big pharma. https://t.co/cLH6e81cf0 136 views · 2 likes · 0 reposts · 0 replies Open on X →

U.S. FDA@FDA27 Aug

@FDA @GeneralMills Did they happen to notice that grains aren't food and their cereals are full of refined sugar while they were at it? 104 views · 2 likes · 0 reposts · 0 replies Open on X →

U.S. FDA@FDA27 Aug

Great news from @GeneralMills – they've completed the removal of certified color from their entire U.S. cereal portfolio and are on track to remove them from all U.S. retail products by 2027! Who’s next? https://t.co/GL5Iq63vQO 16.9K views · 125 likes · 33 reposts · 36 replies Open on X →

U.S. FDA@FDA26 Aug

📢 FDA is hosting a public hearing on the potential future therapeutic use of psychedelic drugs in supervised and supportive settings. Topics include provider training, patient safety, access, and data standardization. Register & learn more: https://t.co/KX47PfOpjU https://t.co/2 12.2K views · 24 likes · 12 reposts · 4 replies Open on X →

U.S. FDA@FDA25 Aug

Today, the FDA announced initial participants selected for the READI-Home Innovation Challenge. The challenge supports devices for use by patients and/or caregivers at home that may address unmet needs and help prevent or reduce hospital readmissions. https://t.co/P9hH7QvFRo http 12K views · 18 likes · 12 reposts · 7 replies Open on X →

На фоне аккаунтов своего размера

23 постов за последние 90 дней рядом с диапазоном 100K–1M подписчиков. обычный охват для своего размера, отклик сильнее, чем у большинства.

Медианные просмотры9 695этот аккаунт5 983медиана для 100K–1M

Охват, %1.64%этот аккаунт1.49%медиана для 100K–1M

Вовлечённость, %1.17%этот аккаунт0.93%медиана для 100K–1M

Показатель	Этот аккаунт	Медиана для 100K–1M	Отношение
Медианные просмотры на пост	9 695	5 983	1.62×
Охват (просмотры ÷ подписчики)	1.64%	1.49%	1.10×
Вовлечённость	1.17%	0.93%	1.26×

Другие в этом диапазоне → Сравнить с другим аккаунтом → Как считаются эти ориентиры →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

1531 Sep

40.7K2 Sep

15.3K4 Sep

9.7K11 Sep

194.9K

9.5K

8.8K

21.2K12 Sep

119.7K15 Sep

10.1K

83.8K

2.3K

1.4K

2.5K

Last 14 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

3.27%1 Sep

0.42%2 Sep

0.47%4 Sep

0.77%11 Sep

0.09%

0.45%

0.29%

0.52%12 Sep

1.19%15 Sep

3.31%

0.66%

6.44%

4.35%

6.12%

Reactions — likes, reposts, replies and quotes — divided by views. Median for 100K–1M accounts is 0.93%.

What the audience does

Likes65.7%2 592 in total

Reposts14.7%582 in total

Replies9.5%375 in total

Quotes3.4%136 in total

Bookmarks6.6%261 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Последние посты

На фоне аккаунтов своего размера

Growth & engagement

Views per post

Engagement rate per post

What the audience does

Похожие аккаунты